日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

USP2 promotes metabolic dysfunction-associated steatotic liver disease progression via stabilization of PPARγ

USP2通过稳定PPARγ促进代谢功能障碍相关的脂肪肝疾病进展。

Luo, Hao; Zhu, Chujiao; Wang, Yingying; Dai, Yidong; Hao, Peng; Cai, Haiyan; Bai, Wenhui; Zhang, Zhenge; Wan, Jiale; Zhang, Youping; Sun, Yun; Zhang, Ziwei; Wu, Yunzhao; Zhai, Yuanhui; Wu, Wenxuan; Lei, Hu; Xu, Hanzhang; He, Ming; Wu, Yingli

USP7 sustains hematopoietic stem cell homeostasis partially via PU.1 stabilization.

USP7 通过 PU.1 稳定作用部分维持造血干细胞稳态。

Shan Huizhuang, Zhang Youping, Xiao Xinhua, Wu Wenxuan, Wang Yingying, Zhu Chujiao, Bai Wenhui, Zhang Ziwei, Zhai Yuanhui, Yang Li, Wu Yunzhao, Lei Hu, Xu Hanzhang, Luo Yanfei, Lu Liming, Wu Yingli

Noscapine derivative 428 suppresses ferroptosis through targeting GPX4.

诺斯卡品衍生物 428 通过靶向 GPX4 抑制铁死亡

Zhang Youping, Shi Haoliang, Wang Yingying, Liu Wanting, Li Guanyi, Li Defeng, Wu Wenxuan, Wu Yunzhao, Zhang Ziwei, Ji Yanjie, Zhu Chujiao, Bai Wenhui, Lei Hu, Xu Hanzhang, Zhong Hua, Han Baohui, Yang Li, Liu Ligen, Wang Wei, Zhao Yaxue, Zhang Yongqiang, Wu Yingli

Targeting USP2 induces degradation of PML-RARα with or without drug-resistant mutations in acute promyelocytic leukemia.

靶向 USP2 可诱导急性早幼粒细胞白血病中 PML-RARα 的降解,无论是否存在耐药突变。

Zhang Jie, Wu Wenxuan, Wang Yun, Zhang Youping, Wang Yingying, Bai Wenhui, Zhang Zhenge, Zhu Chujiao, Wu Yunzhao, Zhang Ziwei, Yang Li, Lei Hu, Xu Hanzhang, Zhou Li, Wu Yingli

Identification of USP2 as a novel target to induce degradation of KRAS in myeloma cells.

鉴定出 USP2 是诱导骨髓瘤细胞中 KRAS 降解的新靶点

Wang Yingying, Zhang Youping, Luo Hao, Wei Wei, Liu Wanting, Wang Weiwei, Wu Yunzhao, Peng Cheng, Ji Yanjie, Zhang Jianfang, Zhu Chujiao, Bai Wenhui, Xia Li, Lei Hu, Xu Hanzhang, Yin Leimiao, Weng Wei, Yang Li, Liu Ligen, Zhou Aiwu, Wei Yueyue, Zhu Qi, Zhu Weiliang, Yang Yongqing, Xu Zhijian, Wu Yingli